Sylvania Platinum — Rise in PGMs and higher production guidance

Sylvania Platinum (AIM: SLP)

Last close As at 30/01/2026

GBP1.10

−12.00 (−9.88%)

Market capitalisation

GBP285m

More on this equity

Research: Metals & Mining

Sylvania Platinum — Rise in PGMs and higher production guidance

Sylvania Platinum’s production in Q226 remained strong at 24,642oz for 4E platinum group metals (PGMs), slightly up on the previous record in Q126. PGM prices started rallying in December 2025, ahead of our expectations. Our new PGM forecasts are between 50% and 90% higher for FY26, driving earnings upgrades. We upgrade FY26 EPS by 52% to 35.2 US cents, FY27 EPS by 133% to 64.8 US cents and FY28 EPS by 143% to 69.0 US cents. Allowing for PGM prices to reverse from FY29 towards our long-term assumptions has resulted in a 24.8% increase in our valuation to 195p per share.

Lord Ashbourne

Written by

Lord Ashbourne

Director of Content, Mining

Metals and mining

Q226 results

2 February 2026

Price 109.50p
Market cap £285m

US$1.32/£; ZAR17.37/US$

Net cash at end Q226

$54.0m

Shares in issue

260.1m
Free float 90.0%
Code SLP
Primary exchange AIM
Secondary exchange N/A
Price Performance
% 1m 3m 12m
Abs 1.4 26.4 138.5
52-week high/low 128.0p 40.5p

Business description

Sylvania Platinum focuses on the re-treatment and recovery of platinum group metals including platinum, palladium and rhodium, mainly from tailings dumps and other surface sources, but also lesser amounts of run-of-mine underground ore from Samancor chrome mines in South Africa.

Next events

H126 results

February 2026

Analysts

Lord Ashbourne
+44 (0)20 3077 5700
Rene Hochreiter
+44 (0)20 3077 5700
Marius Strydom
+44 (0)20 3077 5700

Sylvania Platinum is a research client of Edison Investment Research Limited

Note: PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments.

Year end Revenue ($m) PBT ($m) EPS (¢) DPS (p) P/E (x) Yield (%)
6/25 104.2 27.7 7.73 2.75 19.4 2.5
6/26e 255.6 126.8 35.20 9.00 4.3 8.2
6/27e 389.6 238.1 64.78 12.00 2.3 11.0
6/28e 417.1 256.4 69.19 13.00 2.2 11.9

Record production maintained and guidance lifted

Sylvania’s 4E PGM output has increased for six consecutive quarters to reach a new record in Q226. PGM plant feed tons increased by an impressive 9%, offset by lower plant recoveries and plant feed grade to drive 4E PGM production of 24,642oz. FY26 guidance has been lifted to 90,000–93,000oz and we increase our forecast from 92,000oz to 93,000oz. We reduce our chromite concentrate forecast for FY26 from 102,000t to 90,000t (on updated guidance).

PGM price rally and PGM forecasts upgraded

On top of the record production in Q226, Sylvania’s PGM basket price increased by 21.6% to US$2,374/oz, driving a 21.5% increase in total revenue for the quarter. Over the latter part of December 2025, PGM prices started rallying, with platinum up over 50% and rhodium up almost 35% due to accelerated US stockpiling of critical minerals, with PGMs considered the most critical. We have upgraded our PGM price basket by 34% for FY26 and 77% for FY27 before our forecasts moderate from FY29 and revert to our long-term assumptions from FY31.

Earnings upgrades, after higher costs and tax

Sylvania’s strong revenue delivery in Q226 was accompanied by higher total operating costs due to a much stronger rand and higher royalties tax on much better revenue. We have incorporated the enhanced revenue and increased cost and tax profile into our forecasts, resulting in a 52% upgrade to FY26 EPS and upgrades of 133% and 143% to FY27 and FY28 EPS, respectively.

Valuation: Increased by 24.8% to 195p per share

We have increased our valuation by 24.8% to 195p/share (Sylvania Dump Operations (SDO) up 31.6% to 158.9p, JV up 5.5% to 22.3p and exploration assets down 3.6% to 13.6p due to dollar weakness). Our SDO valuation is very sensitive to rhodium prices and our JV valuation to chrome prices. The development or disposal of exploration assets could add value in a strong PGM environment.

Record production and rising PGM prices with JV ramp-up to follow

Sylvania’s capital expenditure cycle over recent years continues to bear fruit in the form of increased efficiencies and production. During Q226, the company reached a new record quarterly production of 24,642oz 4E PGMs (vs 24,522oz in Q126) with total 6E PGMs of 31,380oz. While the company treated 4.3% more raw materials (8.6% more PGM plant feed), it experienced a 5.5% decline in feed grade and delivered slightly lower plant recovery. The company increased its FY26 production target from 83,000–86,000oz to 90,000–93,000oz and we have lifted our forecast from 92,000oz to 93,000oz. Sylvania moderated its chromite concentrate target for the Thaba joint venture (JV) from 100,000–130,000t to 60,000t– 90,000t due to a slower than anticipated ramp-up. We have reduced our FY26 production forecast from an already conservative level of 102,000t to 90,000t (top of the new guidance range) and maintain our FY27 forecast at 204,000t.

On top of the record production in Q226, Sylvania’s PGM basket price increased by 21.6% to US$2,374/oz from US$1,953/oz in Q126, 5.8% ahead of our forecasts for the quarter. In addition, PGM prices rallied sharply in the latter part of December 2025 and have now far surpassed our previous PGM price forecast profile. The two most material PGMs for Sylvania’s revenue are platinum (up over 50% since the start of December 2025) and rhodium (up almost 35%). We have reviewed and upgraded our PGM price forecasts (see below).

Total revenue for the quarter increased by 21.5% to US$54.8m (after a 49% rise in Q126), driven by 24.6% higher 4E PGM revenue and a large US$5.3m sales adjustment, which relates to the late rally in PGM prices. Total operating costs rose by 9% in rand terms, largely in line with PGM plant feed growth over the period and allowing for higher royalties tax (with the effective royalties tax rate bolstered by strong production and revenue). The growth in dollar terms was 12.3% to US$25m, affected by dollar weakness (on average the dollar was 2.9% weaker than the rand and the 31 December 2025 spot price was 3.8% weaker). SDO cash cost per 4E PGM ounce increased by 3.3% in rand terms and 6.4% in dollar terms. Since quarter-end, the dollar has lost another 4.7% to the rand, which has resulted in higher cost growth forecasts for FY26 and thereafter.

Capital expenditure moderated to US$7.3m over the quarter and is still forecast to peak at US$36m for FY26, after which the company expects it to reduce over the following years. The cash balance reduced by 13.9% to US$54.0m due to a US$6.8m final dividend payment, US$5.7m in tax and capital expenditure, including a further working capital loan of US$5.7m to the JV partner. Together with healthy forecast operating cash generation and the commencement of JV-related debt repayments, we expect the cash balance to start growing healthily from FY27, supporting a progressive dividend policy and increasing the potential for windfall dividends.

On the back of our higher forecast production for FY26, our upgrades to PGM prices and the strong delivery during Q226, we now forecast revenue growth of 145% for the year to US$255.6m (up from US$193.5m in our previous note). After allowing for higher operating costs and royalty taxes (in line with higher revenue), our FY26 EPS has been lifted by 51.7% to 35.2 US cents.

After a ramp-up to full capacity by the end of FY26, we forecast a full-year of production from the JV for FY27. This, together with our higher PGM price forecasts, drives a further 52% forecast increase in revenue during the year, resulting in EPS growth of 84% to 64.8 US cents (up 133% on our previous forecast). We thereafter forecast modest 6.5% growth in EPS for FY28 to 69.0 US cents (up 143% on our previous forecast).

We forecast a healthy increase in the dividend from 2.75p/share in FY25 to 9p/share in FY26 (increased from 7p/share) and 12p/share in FY27 (increased from 10p/share). We forecast a further increase to 13p/share in FY28. While we do not explicitly forecast windfall dividends, we expect these to resume (now in FY26 versus FY27 as mentioned in our previous research) in the current conducive PGM environment.

PGM upgrade on strong rally an improved outlook

Following the strong rally since late-December 2025, we have upgraded our PGM price forecasts, lifting our FY26 basket by 34% to US$3,045/oz (and by 77% to US$4,433/oz for FY27). The most meaningful upgrades are for platinum and palladium.

The publication by the USGS of the American Critical Minerals List and the recognition that China, South Africa and the Democratic Republic of the Congo control the top 15 minerals on the list has, in our view, led to rapid price rises as the US tries to build strategic stocks to meet its needs, especially its armaments and military requirements. All PGMs are included in the list, with rhodium being the most critical. South Africa has 90% of all PGM reserves in the world, and we believe Sylvania, as a South African-based company, stands to benefit significantly from both its geographic positioning and its critical metals production.

Valuation

We have increased our valuation of Sylvania by 25% to 195.0p/share, made up of a 159.2p/share valuation for the SDO (up 31.8%), a 22.3p/share valuation for the JV (up 5.5%) and a 13.6p/share valuation for the exploration assets. The valuation assets are carried at book value, with the 3.6% decline the result of a weaker dollar to sterling.

The forward P/E multiple implied by our FY26 EPS estimate is a very attractive 6.7x, which falls further to 3.6x and 3.4x based on our EPS forecasts for FY27 and FY28, respectively.

General disclaimer and copyright

This report has been commissioned by Sylvania Platinum and prepared and issued by Edison, in consideration of a fee payable by Sylvania Platinum. Edison Investment Research standard fees are £60,000 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright 2026 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or sol icitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

London │ New York │ Frankfurt

20 Red Lion Street

London, WC1R 4PS

United Kingdom

More on Sylvania Platinum

View All

Latest from the Metals & Mining sector

View All Metals & Mining content

Research: Healthcare

Basilea Pharmaceutica — An emphatic start to 2026

As Basilea enters 2026 with elevated operational momentum ahead of its FY25 results, we revisit key developments from 2025 and outline our expectations for the year ahead. Given Cresemba’s continued momentum, we expect global in-market sales to approach US$800m in FY26, driving an uplift in royalty and milestone income for Basilea. Further support should come from Zevtera as the year progresses, with US reimbursement in place and a positive market reception following launch. 2026 has kicked off with multiple early-stage collaborations and we expect this partnering intent to continue through the year. Beyond Cresemba, fosmanogepix and the recently acquired ceftibuten-ledaborbactam (CTB-LEDA) provide medium- to long-term growth optionality, helping offset the expected slowdown following Cresemba’s market maturity in late 2027. Reflecting our updated assumptions, the latest BARDA funding and the CTB-LEDA acquisition, we raise our valuation to CHF118.0/share (from CHF107.4/share).

Continue Reading